High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors.
Vanhoof
J
J
Landewe
S
S
Van Wijngaerden
E
E
Geusens
P
P
D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury; D004347:Drug Interactions; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D012460:Sulfasalazine / Q000009:adverse effects; D014376:Tuberculosis / Q000517:prevention & control*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D014409:Tumor Necrosis Factor-alpha; D012460:Sulfasalazine; D007538:Isoniazid; D008727:Methotrexate